M&A
confidence high
sentiment positive
materiality 0.75
CV Sciences agrees to acquire Extract Labs for $1.4M cash and stock, plus earnout
CV Sciences, Inc.
- Total consideration: $400K cash + $1M in CVSI stock at closing; up to $600K earnout in stock.
- Earnout tied to Extract Labs revenue targets: $3.5M-$4.6M per 12-month period for two years.
- Acquisition expected to close in Q1 2025, subject to customary conditions.
- CV Sciences plans to in-source +PlusCBD production, citing cost savings and supply chain control.
- Extract Labs described as stand-alone profitable, GMP-certified, and FDA-registered.